Petros Pharmaceuticals, Inc.
PTPI· OTC
PTPIPetros Pharmaceuticals, Inc.
Filed Apr 15, 2026 · 10-K · 105 days after period end · 0001104659-26-043822
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $725.40K | — | $798.10K |
| Net Income | -$336.51K | -$9.27M | $318.15K | -$4.22M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petros Pharmaceuticals, Inc. · CIK 1815903 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Apr 15, 2026 · 105 d after period end
